Pancreatic cancer vaccine shows promise in early-stage trial
A pancreatic cancer vaccine, in its early-stage trial, has shown promising results. Results from the trial published on Wednesday in Nature, a scientific journal, show that half of the pancreatic cancer patients who received the treatment, a personalised mRNA cancer vaccine after surgery, did not have a recurrence of the tumour a year and a
Read More